
    
      This is a double-blind and randomized study. Subjects are informed to consume the samples
      every day for 2 months. The clinical diagnosis item of benign prostatic hyperplasia (BPH) is
      evaluated by the doctor. The questionnaires are collected at every visit of the trial.
    
  